
Uterine Surgery, Morcellator, FDA & Cancer: A recent article in published in the American Journal of Orthopedics examined the FDA’s review of risk for women that underwent laparoscopic power morcellation hysterectomy and myomectomy and were later affected by unexpected uterine cancer (e.g., leiomyosarcoma (LMS) or Uterine leiomyosarcoma). The Uterine Surgery, […]